Status:
COMPLETED
Endobronchial Valves in Persistent Air Leak
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Malignant Neoplasm of Lung
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Because an endobronchial valve is a one-way inspiratory airway blocker, it is hypothesized that it could be also used for controlling persistent air leaks while maintaining the drainage of secretions....
Detailed Description
Persistent Air Leak (PAL) is independently associated with prolonged hospital length of stay, decreased patient satisfaction, increased morbidity or postoperative complications, and adds significantly...
Eligibility Criteria
Inclusion
- Prolonged (≥10 days postoperative) persistent air leak refractory to conventional treatments (such as prolonged drainage and/or chemical pleurodesis).
- Anatomical lung resection such as segmentectomy, (bi)lobectomy or sleeve lobectomy.
- Air leak after antero/posterolateral thoracotomy or video-assisted thoracoscopy (VATS).
- Type of air leak : expiratory.
- Size of air leak : any.
Exclusion
- Prolonged air leak \<10 days postoperative.
- Pneumonectomy or none-anatomical lung resection.
- Lung resection for another indication than cancer.
- Previous reintervention or previous Heimlich valve for this air leak.
- Empyema
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01451359
Start Date
October 1 2011
End Date
October 1 2013
Last Update
October 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Leuven
Leuven, Belgium